M&T Bank’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,434
Closed -$246K 1658
2024
Q2
$246K Buy
+8,434
New +$250K ﹤0.01% 1399
2015
Q3
Sell
-12,139
Closed -$334K 1898
2015
Q2
$334K Sell
12,139
-761
-6% -$20.3K ﹤0.01% 1418
2015
Q1
$326K Buy
12,900
+107
+0.8% +$2.53K ﹤0.01% 1396
2014
Q4
$283K Sell
12,793
-3,185
-20% -$64.6K ﹤0.01% 1528
2014
Q3
$325K Buy
+15,978
New +$318K ﹤0.01% 1508

Other funds holding IART

M&T Bank's IART Position: Q3 2024 in Review

M&T Bank sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 8,434 shares — an estimated $246K sold.

M&T Bank first reported a position in IART in Q3 2014 and held it in 5 quarters. The position peaked at $334K in Q2 2015. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • M&T Bank reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • M&T Bank sold 8,434 Integra LifeSciences shares in Q3 2024, an estimated $246K.
  • M&T Bank first reported a position in Integra LifeSciences in Q3 2014 and held it in 5 quarters.
  • M&T Bank's Integra LifeSciences position peaked at $334K in Q2 2015.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on M&T Bank's 13F filing for Q3 2024, filed 15 Nov 2024.